Skip to main content

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

2.018 +0.068 (+3.46%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jun 10, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 186
Open 2.018
Bid (Size) 1.950 (1)
Ask (Size) 2.090 (1)
Prev. Close 1.950
Today's Range 2.018 - 2.018
52wk Range 1.120 - 4.200
Shares Outstanding N/A
Dividend Yield N/A

Performance

YTD
-38.7%
-38.7%
1 Month
-7.9%
-7.9%
3 Month
+1.4%
+1.4%
6 Month
-37.1%
-37.1%
1 Year
+23.8%
+23.8%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 2.018
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 06/10/25 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.